Evidence map›Paper›PMID 31448049›Full record

ArticleOncotarget2019

Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in

Maria Zamkova, Anastasiya Kalinina, Yuliya Silaeva, Nadezhda Persiyantseva, Alexandra Bruter, Alexey Deikin, Ludmila Khromykh, Dmitry Kazansky

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria Zamkova *"N. N. Blokhin National Medical Research Centre of Oncology" of the Health Ministry of Russia, Moscow, Russia.
Anastasiya Kalinina *"N. N. Blokhin National Medical Research Centre of Oncology" of the Health Ministry of Russia, Moscow, Russia.
Yuliya Silaeva *Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Nadezhda Persiyantseva"N. N. Blokhin National Medical Research Centre of Oncology" of the Health Ministry of Russia, Moscow, Russia.
Alexandra BruterRussian Academy of Sciences, Engelhardt Institute of Molecular Biology, Moscow, Russia.
Alexey DeikinInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Ludmila Khromykh"N. N. Blokhin National Medical Research Centre of Oncology" of the Health Ministry of Russia, Moscow, Russia.
Dmitry Kazansky"N. N. Blokhin National Medical Research Centre of Oncology" of the Health Ministry of Russia, Moscow, Russia.
Institute of Gene Biology · RUEngelhardt Institute of Molecular Biology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both TCRα and TCRβ types of T-cell receptors contribute to antigen recognition. However, some TCRs have chain centricity, which means that either the α-chain or the β-chain dictates the peptide-MHC complex specificity. Most earlier reports investigated the role of well-studied β-chains in antigen recognition by TCRαβ. In a previous study, we identified TCRs specific to the H-2K

Indexed as

alloantigenTCRαtransgenic micetumor

Identifiers

PMID31448049
PMCPMC6690675
OpenAlexW2969443687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.